Unique ID issued by UMIN | UMIN000032697 |
---|---|
Receipt number | R000037165 |
Scientific Title | Evaluation of safety and efficacy of perioperative administration of TJ-100 in patients with postoperative functional aberration of the gastrointestinal tract due to surgery for colon cancer |
Date of disclosure of the study information | 2018/05/24 |
Last modified on | 2019/05/26 13:33:25 |
Evaluation of safety and efficacy of perioperative administration of TJ-100 in patients with postoperative functional aberration of the gastrointestinal tract due to surgery for colon cancer
Evaluation of safety and efficacy of perioperative administration of TJ-100 in patients with postoperative functional aberration of the gastrointestinal tract due to surgery for colon cancer
Evaluation of safety and efficacy of perioperative administration of TJ-100 in patients with postoperative functional aberration of the gastrointestinal tract due to surgery for colon cancer
Evaluation of safety and efficacy of perioperative administration of TJ-100 in patients with postoperative functional aberration of the gastrointestinal tract due to surgery for colon cancer
Japan |
colon cancer
Surgery in general | Gastrointestinal surgery |
Malignancy
NO
To determine whether perioperative administration of TJ-100 affects postoperative recovery of gastrointestinal function in patients undergoing surgery for colon cancer
Safety,Efficacy
the time until first flatus following colon surgery
1.The time until first defecation following colon surgery
2.CRP, WBC, neutrophil of POD 1,3
3.The maximumu of body temperature
4.Hospital stay after colorectal surgery
5.Postoperative complication
6.Adverse events
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
oral administration of TJ-100(15g/day) in perioperative surgery
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients with curative resection for colon cancer including cancer of the rectosigmoid that had been diagnosed pre-operatively
2.Patients with a performance status of 0 or 1
3.Patients able to tolerate oral administration of TJ-100
4.Patients aged 20 years or older
5.Patients able to provide written informed consent
1.Patients taking other Kampo medicines
2.Patients were pregnant, possibly pregnant or considering pregnancy
3.Patients with serious ischemic heart disease
4.Patients with cirrhosis or active hepatitis
5.Patients with dyspnea requiring oxygen administration
6.Patients under dialysis due to chronic renal failure
7.Patients requiring combined resection of any other organ
8.Patients ineligible for the study for any other reason, as judged by the investigator
200
1st name | Ichiro |
Middle name | |
Last name | Takemasa |
Sapporo Medical University
Department of Surgery, Surgical Oncology and Science
060-8543
Sapporo, Hokkaido 060-8543, Japan
011-611-2111
itakemasa@sapmed.ac.jp
1st name | Toshihiko |
Middle name | |
Last name | Nishidate |
Sapporo Medical University
Department of Surgery, Surgical Oncology and Science
060-8543
Sapporo, Hokkaido 060-8543, Japan
011-611-2111
nisidate@sapmed.ac.jp
Sapporo Medical University
Sapporo Medical University
Other
Sapporo Medical University
Sapporo, Hokkaido 060-8543, Japan
011-611-2111
rskk@sapmed.ac.jp
NO
2018 | Year | 05 | Month | 24 | Day |
Unpublished
Completed
2017 | Year | 12 | Month | 14 | Day |
2017 | Year | 12 | Month | 15 | Day |
2018 | Year | 01 | Month | 18 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 31 | Day |
2018 | Year | 05 | Month | 24 | Day |
2019 | Year | 05 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037165